Land: Storbritannia
Språk: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Phenoxymethylpenicillin potassium
Bristol Laboratories Ltd
J01CE02
Phenoxymethylpenicillin potassium
250mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010101; GTIN: 5060013941122
SAME SIZE ARTWORK 220 x 140 mm Front 24 mm 220 mm 140 mm IXXXXXX PACKAGE LEAFLET: INFORMATION FOR THE USER PHENOXYMETHYLPENICILLIN 250 mg TABLETS BP Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4. What is in this leaflet 1. What Penicillin tablets are and what they are used for 2. What you need to know before you take Penicillin tablets 3. How to take Penicillin tablets 4. Possible side effects 5. How to store Penicillin tablets 6. Contents of the pack and other information 1. What Penicillin tablets are and what they are used for The name of your medicine is Phenoxymethylpenicillin 250mg tablets BP referred as Penicillin tablets in this leaflet. The active ingredient is Phenoxymethylpenicillin potassium. • Phenoxymethylpenicillin belongs to a group of medicines called penicillins, which are used to fight bacteria that cause infections. • These tablets are used to treat a wide range of bacterial infections of the ear, throat, respiratory tract, skin and soft tissues. • It may also be used to prevent: - rheumatic fever or chorea (infection of the nervous system) recurring - infection in patients without a spleen (abdominal organ) - prevent pneumococcal infection (e.g. in asplenia and in patients with sickle cell disease). 2. What you need to know before you take Penicillin tablets Do not take this medicine if you: • are allergic to phenoxymethylpenicillin, any other penicillins or cephalosporins or any other ingredients (listed in Section 6) Warnings and Precautions Talk to your doctor or pharmacist before takin read_full_document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Phenoxymethylpenicillin 250 mg Tablets BP 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Phenoxymethylpenicillin 250 mg (as Phenoxymethylpenicillin Potassium) For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablet White to off white round biconvex film-coated tablets with BL/250 debossed on one side. 4.1 THERAPEUTIC INDICATIONS Phenoxymethylpenicillin is indicated in the treatment or prophylaxis of mild to moderately severe infections caused by penicillin sensitive organisms, i.e. those microorganisms whose susceptibility to phenoxymethylpenicillin is within the range of serum levels attained. Recommended for use in the treatment of infections caused by susceptible organisms including Staphylococci, Pneumococci, Gonococci and Haemolytic Streptococci. Phenoxymethylpenicillin is indicated for the treatment of the following infections (see section 4.4 and 5.1) Streptococcal infections: Pharyngitis Scarlet fever Skin and soft tissue infections (e.g. erysipelas) Pneumococcal infections: Pneumonia Otitis media Vincent’s gingivitis and pharyngitis Phenoxymethylpenicillin is also indicated for (see section 5.1): Prophylaxis of rheumatic fever and/or chorea Prophylaxis of pneumococcal infection (e.g. in asplenia and in patients with sickle cell disease Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The dosage and frequency of Phenoxymethylpenicillin depends on the severity and localisation of the infection and expected pathogens. The usual dosage recommendations are as follows: Adults and children over 12 years): 250-500mg every 6 hours Children: Infants (1 month to 1 year): 62.5mg every six hours 1 - 5 years : 125 mg every six hours 6-12 years : 250 mg every six hours Prophylactic Use Prophylaxis of rheumatic fever/chorea: 250mg twice daily on a continuing basis Prophylaxis of pneumococcal infection (e.g. in asplenia and in s read_full_document